Skip to content

Study · Not a test of the peptide alone · 1993

1 result

H-Gly-His psi (NHCO)Lys-OH, partially modified retro-inverso analogue of the growth factor glycyl-L-histidyl-L-lysine with enhanced enzymatic stability.

Dalpozzo A, Kanai K, Kereszturi G, Calabrese G

International journal of peptide and protein research1 Jun 1993Cited by 8 (Europe PMC)

PMID8349414 (opens in a new tab)DOI10.1111/j.1399-3011.1993.tb00478.x (opens in a new tab)PepBankPUB-08349414
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, GHK (glycyl-L-histidyl-L-lysine) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking GHK (glycyl-L-histidyl-L-lysine).

  1. 01LabNot a test of GHK (glycyl-L-histidyl-L-lysine) aloneIn vitro (cell-free)Other

    In human plasma in vitro, a partially retro-inverso GHK analogue showed approximately ten-fold greater stability than parent GHK.

    In plain wordsIn lab tests, a modified GHK analogue was approximately ten-fold more stable than parent GHK.

    Peptide
    GHK (glycyl-L-histidyl-L-lysine)
    Outcome
    IncreaseAnalogue enzymatic stability
    Study

    n: not reported in source

    human plasma in vitro
    Comparator
    Parent GHK peptide
    Outcome group
    Pharmacokinetics · Pharmacology

    Source sentences

    Summary
    When evaluated with respect to resistance toward degradation by human plasma in vitro, the new peptide analogue showed approximately a ten-fold increase in stability versus the parent peptide.

    In this study, GHK (glycyl-L-histidyl-L-lysine) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHK (glycyl-L-histidyl-L-lysine).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.